Strana 1 od 29 výsledky
OBJECTIVE
To measure and compare the incidence of adverse events during use of two medicated intrauterine devices (IUDs).
METHODS
A multicenter prospective 7-year randomized study.
METHODS
Family planning clinics, primarily in developing countries.
METHODS
Women age 18 to 38 years at admission,
(1) The reference treatment for uterine leiomyoma with major symptoms is surgery. (2) Leuprorelin and triptorelin, two Gn-RH analogues, are the first drugs to be licensed in France for preoperative treatment of uterine leiomyoma associated with anaemia, when a reduction in the size of the leiomyoma
BACKGROUND
The delivery of combination contraceptive steroids from a transdermal contraceptive patch or a contraceptive vaginal ring offers potential advantages over the traditional oral route. The transdermal patch and vaginal ring could require a lower dose due to increased bioavailability and
In a multicenter, randomized, open, comparative trial, patients with uncomplicated gonorrhea were treated with 400 mg of oral fleroxacin or 250 mg of intramuscular ceftriaxone. A total of 458 men and 447 women were enrolled. Of these, 312 men (68%) and 245 women (55%) were evaluable for efficacy.
Patients with unspecific symptoms were sometimes tested for Candida. In case of findings of this yeast-like fungus in their stools they often were labelled with the diagnosis of a "Candida-syndrome". This comprises headache, weakness, flatulence, ravenous appetite for sweets, itching skin and
OBJECTIVE
To analyze the physiology of menopause in the context of the age at menopause, its pattern, climacteric symptoms and associated problems of an urban cohort.
METHODS
Cross-sectional, analytical study.
METHODS
Four urban sectors of Hyderabad city, from September to October 2004.
METHODS
In
BACKGROUND
Quality of life (QOL) is impaired in functional dyspepsia (FD). Little is known about the effects of different therapies on the QOL profile in patients with this condition.
OBJECTIVE
The aims of this study were to measure baseline QOL in patients with FD and to assess changes in QOL over
Ertapenem, a carbapenem antibacterial, has in vitro activity against many Gram- negative (including Enterobacteriaceae) and Gram-positive aerobic and anaerobic bacteria that are commonly associated with various infections.Once-daily parenteral (intravenous or intramuscular) ertapenem 1g was as
Two different doses of cefaclor advanced formulation (AF), a new sustained-release formulation of cefaclor, were compared with the regular formulation of cefaclor for efficacy and safety in the treatment of uncomplicated cystitis and asymptomatic bacteriuria. A 7-day course of treatment was used,
In a primary care setting, the efficacy and safety of ciprofloxacin (CIP) 500 mg b.i.d. were compared with those of cefuroxime axetil (CA) 250 mg b.i.d., each given for 10 days, in a nationwide, open, prospective, randomized trial of 1414 adults with acute sinusitis. Patients were enrolled if they
OBJECTIVE
To evaluate the safety and efficacy of Menorest 50 in two clinical trials.
METHODS
Menorest 50 was evaluated in two trials: the first was a parallel-group, randomized double-bind study vs. Premarin 0.625 mg/day in 214 women while the second was a parallel-group, open-label trial versus
BACKGROUND
Antibiotic treatment of acute bronchitis, which is one of the most common illnesses seen in primary care, is controversial. Most clinicians prescribe antibiotics in spite of expert recommendations against this practice.
OBJECTIVE
The objective of this review was to assess the effects of
BACKGROUND
Although both internal medicine (IM) and family practice (FP) physicians frequently provide care for the same common adult conditions, IM and FP residency programs differ in their training emphases.
OBJECTIVE
To assess differences in IM and FP residents' self-perceived preparedness to
OBJECTIVE
Treatment of menorrhagia with levonorgestrel intrauterine system (LNG IUS) and transcervical resection.
METHODS
An open, therapeutic, randomized study.
METHODS
Central county hospital specializing in hysteroscopy.
METHODS
Two parallel groups of 30 subjects each.
METHODS
Thirty patients had
NuvaRing is a novel combined contraceptive vaginal ring that releases 15 μg of ethinylestradiol and 120 μg etonogestrel per day. Each ring is used for one cycle, comprising 3 weeks continuous use of the ring followed by a 1-week ring-free period. The contraceptive efficacy and safety of NuvaRing